Literature DB >> 207846

The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii.

E R Pfefferkorn, L C Pfefferkorn.   

Abstract

We have previously reported the isolation and preliminary characterization of a mutant of Toxoplasma gondii that was resistant to adenine arabinoside. Fiftyfold higher concentrations of adenine arabinoside were required to inhibit the growth of the resistant parasite in human fibroblast cultures. To determine the enzymic basis for resistance, we measured the kinases and deaminases that act on adenosine or deoxyadenosine. All of these enzymic activities were found in uninfected human fibroblast cells. The mutant and wild type parasite proved to have similar activities of adenosine deaminase, deoxyadenosine deaminase, and deoxyadenosine kinase. However, the adenine arabinoside resistant mutant had less than 0.1% of the adenosine kinase activity observed in the wild type T. gondii. The mutant parasite is presumably resistant because without adenosine kinase to phosphorylate adenine arabinoside it cannot carry out the first step in the conversion of the analogue to adenine arabinoside triphosphate, the active form. A mutant of 3T6 (mouse) cells previously selected for a loss of adenosine kinase also proved to be resistant to adenine arabinoside.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207846

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  12 in total

1.  Generation of a restriction fragment length polymorphism linkage map for Toxoplasma gondii.

Authors:  L D Sibley; A J LeBlanc; E R Pfefferkorn; J C Boothroyd
Journal:  Genetics       Date:  1992-12       Impact factor: 4.562

2.  Phenotypic and gene expression changes among clonal type I strains of Toxoplasma gondii.

Authors:  Asis Khan; Michael S Behnke; Ildiko R Dunay; Michael W White; L David Sibley
Journal:  Eukaryot Cell       Date:  2009-10-02

3.  Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.

Authors:  M H el Kouni; V Guarcello; O N Al Safarjalani; F N Naguib
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Biochem Pharmacol       Date:  2010-06-10       Impact factor: 5.858

5.  Establishment of a murine cell line resistant to arabinosyladenine and devoid of adenosine deaminase activity.

Authors:  C Shipman; S L Tong; S H Smith; N B Katlama; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

6.  In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism.

Authors:  S A Queen; D L Jagt; P Reyes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

7.  Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.

Authors:  Young Ah Kim; Ashoke Sharon; Chung K Chu; Reem H Rais; Omar N Al Safarjalani; Fardos N M Naguib; Mahmoud H el Kouni
Journal:  Biochem Pharmacol       Date:  2007-01-21       Impact factor: 5.858

8.  Purine metabolism in the protozoan parasite Eimeria tenella.

Authors:  C C Wang; P M Simashkevich
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.

Authors:  Omar N Al Safarjalani; Reem H Rais; Young Ah Kim; Chung K Chu; Fardos N M Naguib; Mahmoud H el Kouni
Journal:  Biochem Pharmacol       Date:  2008-08-07       Impact factor: 5.858

Review 10.  Development of forward genetics in Toxoplasma gondii.

Authors:  L David Sibley
Journal:  Int J Parasitol       Date:  2009-02-28       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.